Published in Women's Health Weekly, July 22nd, 2004
According to a study from Italy, "Oral bisphosphonates are established therapeutics for postmenopausal osteoporosis. Alternative, simplified dosing regimens that improve tolerability and promote convenience may be advantageous.
"Ibandronate is a highly potent, nitrogen-containing bisphosphonate that can be administered as a convenient intravenous (iv) injection (over 15-30 seconds) in schedules featuring extended between-dose intervals," reported S. Adami and colleagues in a recent issue of the journal Bone (Efficacy...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly